1-8 of 8
Pengling Sun
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Marstacimab Prophylaxis in Hemophilia A/B With Inhibitors: Results from the Phase 3 BASIS Trial

Open Access
Clinical Trials & Observations
Davide Matino, Suchitra Acharya, Carrie Turich Taylor, Pengling Sun, Delphine Agathon, Sangeeta Raje, Travis Gould, Andrew Palladino, Johnny Mahlangu
Journal: Blood
Blood blood.2025031065.
https://doi.org/10.1182/blood.2025031065
Published: 2025
Includes: Supplemental data
Journal Articles

Management of breakthrough bleeds in participants with hemophilia Α or Β without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS study

Free
Davide Matino, Hae Kyung Kim, Carrie Turich Taylor, Pengling Sun, Travis Gould, Andrew Palladino
Journal: Blood
Blood (2025) 146 (Supplement 1): 3066.
https://doi.org/10.1182/blood-2025-3066
Published: 2025
Journal Articles

Marstacimab prophylaxis in participants with Hemophilia A or B with inhibitors: Results from the Phase 3 BASIS trial

Free
Davide Matino, Suchitra Acharya, Carrie Turich Taylor, Pengling Sun, Delphine Agathon, Travis Gould, Andrew Palladino, Johnny Mahlangu
Journal: Blood
Blood (2025) 146 (Supplement 1): 306.
https://doi.org/10.1182/blood-2025-306
Published: 2025
Journal Articles

Outcomes of marstacimab treatment in adolescent participants with Hemophilia A or B without inhibitors compared with prior routine prophylaxis: Results from the phase 3 BASIS trial

Free
Anthony Chan, Andrew Palladino, Priya Patel, Pascal Klaus, Pengling Sun, Carrie Turich Taylor, Sangeeta Raje, Francesca Biondo
Journal: Blood
Blood (2025) 146 (Supplement 1): 4845.
https://doi.org/10.1182/blood-2025-4845
Published: 2025
Journal Articles

Long term effect of marstacimab prophylaxis in hemophilia Α and Β on target joints: Results from BASIS and OLE studies

Free
Víctor Jiménez-Yuste, Johnny Mahlangu, Hae Kyung Kim, Travis Gould, Eugeny Mefyod, Pengling Sun, Bryan McComb, Carrie Turich Taylor, Andrew Palladino
Journal: Blood
Blood (2025) 146 (Supplement 1): 4844.
https://doi.org/10.1182/blood-2025-4844
Published: 2025
Journal Articles

Characterization of participants with elevated bleeding rates responding to prophylactic marstacimab treatment in the phase 3 BASIS trial

Free
Young-Shil Park, Fahri Sahin, Laurent Frenzel, Davide Matino, Pascal Klaus, Priya Patel, Pengling Sun, Carrie Turich Taylor, Andrew Palladino
Journal: Blood
Blood (2025) 146 (Supplement 1): 4838.
https://doi.org/10.1182/blood-2025-4838
Published: 2025
Journal Articles

Use of Fidanacogene Elaparvovec, a Gene Therapy Vector, to Deliver a Stable, Fully Functional Human Factor IX Transgene for the Treatment of Hemophilia B: A Combined Analysis of Safety

Free
Ben Samelson-Jones, Laurent Frenzel, Kaan Kavakli, Adam Cuker, Jerome M. Teitel, Pengling Sun, Lisa J Wilcox, Francesca Biondo, Benjamin Hutter, John McKay, Delphine Agathon, Frank Plonski
Journal: Blood
Blood (2024) 144 (Supplement 1): 3577.
https://doi.org/10.1182/blood-2024-193453
Published: 2024
Journal Articles

Characterizing a Cohort of Patients with Hemophilia B Treated with Fidanacogene Elaparvovec from the Phase 3 Benegene-2 Study Who Returned to Factor IX Prophylaxis

Free
Laurent Frenzel, Kaan Kavakli, Robert Klamroth, Shyh-Shin Chiou, Amy D. Shapiro, Pengling Sun, Joanne Fuiman, John McKay, Annie F. Fang, Francesca Biondo, Frank Plonski, Jeremy Rupon
Journal: Blood
Blood (2023) 142 (Supplement 1): 2257.
https://doi.org/10.1182/blood-2023-181223
Published: 2023